Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Cluster of differentiation 177 (CD177) is a known neutrophil antigen.
• Its role in solid tumor pathogenesis is largely unexplored.

Purpose of the Study:

• To identify novel immune molecules involved in cancer pathogenesis.
• To investigate the function of CD177 in breast cancer and other solid tumors.

Main Methods:

• Correlation analysis of CD177 expression with patient survival data.
• Analysis of CD177 expression in normal versus cancerous breast tissues.
• Investigation of CD177's role in mammary epithelial proliferation.
• Assessment of CD177's impact on Wnt/β-catenin signaling.

Main Results:

• CD177 expression positively correlates with improved relapse-free, metastasis-free, and overall survival in breast cancer.
• CD177 expression is also linked to good prognosis in prostate, cervical, and lung cancers.
• CD177 is downregulated in invasive breast cancers, and its loss promotes mammary epithelial hyperproliferation.
• CD177 deficiency is associated with increased β-catenin signaling.

Conclusions:

• CD177 is a novel regulator of mammary epithelial proliferation and breast cancer pathogenesis.
• CD177 likely modulates Wnt/β-catenin signaling, a critical pathway in multiple cancer types.